1. |
Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, all issue of birth and death[J]. Br J Ophthalmol, 2009, 93(9): 1129-1l31. DOI: 10.1136/bjo.2008.150292.
|
2. |
Ortiz MV, Dunkel IJ. Retinoblastoma[J]. J Child Neurol, 2016, 31(2): 227-236. DOI: 10.1177/0883073815587943.
|
3. |
Delhiwala KS, Vadakkal IP, Mulay K, et al. Retinoblastoma: an update[J]. Semin Diagn Pathol, 2016, 33(3): 133-140. DOI: 10.1053/j.semdp.2015.10.007.
|
4. |
中华医学会眼科学分会眼底病学组, 中华医学会儿科学分会眼科学组, 中华医学会眼科学分会眼整形眼眶病学组. 中国视网膜母细胞瘤诊断和治疗指南(2019年)[J]. 中华眼科杂志, 2019, 55(10): 726-738. DOI: 10.3760/cma.j.issn.0412-4081.2019.10.003.Ocular Fundus Diseases Group of Ophthalmological Society in Chinese Medical Association, Ophthalmology Group of Pediatric Society in Chinese Medical Association, Ophthalmic Orthopedics and Orbitology Group of Ophthalmological Society in Chinese Medical Association. Guidelines for diagnosis and treatment of retinoblastoma in China (2019)[J]. Chin J Ophthalmol, 2019, 55(10): 726-738. DOI: 10.3760/cma.j.issn.0412-4081.2019.10.003.
|
5. |
MurPhree AL. Intraocular retinoblastoma: the case for a new group classification[J]. Ophthalmol Clin North Am, 2005, 18: 41-53. DOI: 10.1016/j.ohc.2004.11.003.
|
6. |
国家卫生健康委员会办公厅. 新型冠状病毒感染的肺炎防控方案(第五版)[EB/ OL]. [2020-02-21].Novel coronavirus pneumonia prevention and control scheme (Fifth edition)[EB/OL]. [2020-02-21].
|
7. |
Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture[J]. Invest Ophthalmol Vis Sci, 2005, 46(8): 2683-2691. DOI: 10.1167/iovs.04-1462.
|
8. |
Soliman SE, Racher H, Zhang C, et al. Genetics and molecular diagnostics in retinoblastoma-an update[J]. Asia Pac J Ophthalmol, 2017, 6(2): 197-207. DOI: 10.22608/APO.201711.
|
9. |
Chintagumpala M, Chevez-Barrios P, Paysse EA, et al. Retinoblastoma: review of current management[J]. Oncologist, 2007, 12(10): 1237-1246. DOI: 10.1634/theoncologist.12-10-1237.
|
10. |
Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975-2004[J]. Br J Ophthalmol, 2009, 93(1): 21-23. DOI: 10.1136/bjo.2008.138750.
|
11. |
Subha L, Reddy AS, Ramyaa. A clinical study of retinoblastoma[J]. J Pharm Bioallied Sci, 2015, 7(Suppl 1): S2-3. DOI: 10.4103/0975-7406.155761.
|
12. |
刘万丽, 吴中耀, 杨华胜, 等. 视网膜母细胞瘤的生存率和预后因素研究[J]. 中华临床医师杂志(电子版), 2010, 4(5): 597-602. DOI: 10.3969/cma.j.issn.1674-0785.2010.05.013.Liu WL, Wu ZY, Yang HS, et al. Survival rate and prognostic factors of retinoblastoma[J]. Chin J of Clin (Electronic Edition), 2010, 4(5): 597-602. DOI: 10.3969/cma.j.issn.1674-0785.2010.05.013.
|
13. |
Friedman DL, Himelstein B, Shields CL, et a1. Chemoreduction and localophthalmic therapy for intraocular retinoblastoma[J]. J Clin Oncol, 2000, 18(6): 12-17. DOI: 10.1200/JCO.2000.18.1.12.
|
14. |
罗鑫, 叶慧菁, 杜毅, 等. 视网膜母细胞瘤临床特征及预后分析[J]. 中国实用眼科杂志, 2015, 33(5): 483-487. DOI: 10.3760/cma.j.issn.1006-4443.2015.005.010.Luo X, Ye HJ, Du Y, et al. Clinical characteristics and prognosis of retinoblastoma[J]. Chin J Pract Ophthalmol, 2015, 33(5): 483-487. DOI: 10.3760/cma.j.issn.1006-4443.2015.005.010.
|